Citrullination of self-proteins and autoimmunity

Scandinavian Journal of Immunology

Volumn 60, Issue 1, 2004, Pages 112-120

  Rubin, B ^a   Sonderstrup G ^b  

^a CHU PURPAN   (France)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CITRULLINE; FIBRINOGEN; HLA DR4 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; CROSS REACTION; DISEASE PREDISPOSITION; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

ANIMALS; ANTIBODIES; ARTHRITIS, RHEUMATOID; CD4-POSITIVE T-LYMPHOCYTES; CITRULLINE; CROSSES, GENETIC; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRINOGEN; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA-DR4 ANTIGEN; HUMANS; IMMUNIZATION; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED CBA; MICE, INBRED DBA;

EID: 3242681759     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0300-9475.2004.01457.x     Document Type: Article

References (66)

1. Davis MM, Björkman PJ. T cell antigen receptor genes and T cell recognition. Nature 1988;334:395-402.
2. Bouneaud C, Kourilsky P, Bousso P. Impact of negative selection on the T cell repertoire to a self-peptide: a large fraction of T cell clones escapes clonal deletion. Immunity 2000;13:829-40.
3. Huseby ES, Crawford F, White J, Kappler J, Marrack P. Negative selection imparts peptide specificity to mature T cell repertoire. Proc Natl Acad Sci USA 2003;100:11565-70.
4. Davis SJ, Ikemizu S, Evans EJ et al. The nature of molecular recognition by T cells. Nat Immunol 2003;4:217-24.
5. Gregersen PK, Silver J, Winchester RJ. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 1987;30:315-32.
6. Sønderstrup G. Development of humanized mice as a model of inflammatory arthritis. Springer Semin Immunopathol 2003;25:35-45.
7. Sakagushi N, Takahashi T, Hata H et al. Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice. Nature 2003;426:454-60.
8. Simon DI, Ezratty AM, Francis SA, Rennke H, Loscalzo J. Fibrin (ogen) is internalized and degraded by activated human monocytoid cells via Mac-1: a nonplasmin fibrinolytic pathway. Blood 1993;82:2414-22.
9. Perera PY, Mayadas TN, Takeuchi O et al. CD11c/CD18 acts in concert with CD14 and Toll-like receptor (TLR) 4 to elicit full lipopolysaccharide and taxol-inducible gene expression. J Immunol 2001;166:574-81.
10. Smiley ST, King JA, Hancock WW. Fibrinogen stimulates chemokine secretion through Toll-like receptor 4. J Immunol 2001;167:2887-94.
11. Atsumi T, Ishihara K, Kamimura D et al. A point mutation of Tyr-759 in interleukin 6 family cytokine receptor subunit pg130 causes autoimmune arthritis. J Exp Med 2002;196:979-90.
12. Holmdahl R, Andersson M, Goldschmidt TJ et al. Type II collagen autoimmunity in animals and provocations leading to arthritis. Immunol Rev 1990;118:193-232.
13. Roth S, Willcox N, Rzepka MP, Mayer MP, Melchers I. Major differences in antigen-processing correlate with a single Arg71<->lys substitution in HLA-DR molecules predisposing to rheumatoid arthritis and with their selective interactions with 70-kDa heat shock protein chaperones. J Immunol 2002;169:3015-20.
14. Cope AP, Patel SD, Hall F et al. T cell responses to a human cartilage autoantigen in the context of rheumatoid arthritis-associated and non-associated HLA-DR4 alleles. Arthritis Rheum 1999;42:1497-507.
15. Korganow AS, Ji H, Mangialaio S et al. From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins. Immunity 1999;10:451-61.
16. Masson-Bessière C, Sebbag M, Girbal-Heuseuser E et al. The major synovial targets of rheumatoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the α and β chains of fibrin. J Immunol 2001;166:4177-84.
17. Ji H, Ohmura K, Mahmood U et al. Arthritis critically dependent on innate immune system players. Immunity 2002;16:157-68.
18. Wipke BT, Allen P. Essential role of neutrophils in the initiation and progression of a murine model of rheumatoid arthritis. J Immunol 2001;167:1601-8.
19. Lee DM, Friend DS, Gurish MF et al. Mast cells: a cellular link between autoantibodies and inflammatory arthritis. Science 2002;297:1689-92.
20. Coutinho A, Kazatchkine MD, Avrameas S. Natural autoantibodies. Curr Opin Immunol 1995;7:812-8.
21. Maccioni M, Zeder-Lutz G, Huang H et al. Arthritogenic monoclonal antibodies from K/BxN mice. J Exp Med 2002;195:1071-7.
22. Kumar V, Sercarz EE. An integrated model of regulation centered on recognition of TCR peptide/MHC complexes. Immunol Rev 2001;181:113-21.
23. Parish NM, Hutchings PR, O'Reilly L et al. Tolerance induction as a therapeutic strategy for the control of autoimmune endocrine disease in mouse models. Immunol Rev 1995;144:269-300.
24. Anderton SM, Wraith DC. Selection and fine-tuning of the autoimmune T-cell repertoire. Nat Rev Immunol 2002;2:487-98.
25. Furie B, Furie BC. The molecular basis of blood coagulation. Cell 1998;53:505-17.
26. Brown JH, Volkmann N, Jun G, Henschen-Edman AH, Cohen C. The crystal structure of modified bovine fibrinogen. Proc Natl Acad Sci USA 2000;97:85-90.
27. Yang Z, Mochalkin I, Veerapandian L, Riley M, Doolittle RF. Crystal structure of native chicken fibrinogen at 5.5-A resolution. Proc Natl Acad Sci USA 2000;97:3907-12.
28. Trezzini C, Schüepp B, Maly FE, Jungi TW. Evidence that exposure to fibrinogen or to antibodies directed against Mac-1 modulates human monocyte effector functions. Br J Haematol 1991;77:16-24.
29. Johnson LL, Berggren KN, Szaba FM, Chen W, Smiley ST. Fibrinmediated protection against infection-stimulated immunopathology. J Exp Med 2003;197:801-6.
30. Caramalho I, Lopes-Carvalho T, Ostler D et al. Regulatory T cells selectively express Toll-like receptors and are activated by lipopolysaccharide. J Exp Med 2003;197:403-11.
31. Suh TT, Holmback K, Jensen NJ et al. Resolution of spontaneous bleeding events but failure of pregnancy in fibrinogen-deficient mice. Genes Dev 1995;7:2020-33.
32. Yang YH, Carmeliet P, Hamilton JA. Tissue-type plasminogen activator deficiency exacerbates arthritis. J Immunol 2001;167:1047-52.
33. Busso N, Péclat V, van Ness K et al. Exacerbation of antigen-induced arthritis in urokinase-deficient mice. J Clin Invest 1998;102:41-50.
34. Kobari Y, Misaki Y, Setogushi K et al. T cells accumulating in the inflamed joints of a spontaneous murine model of rheumatoid arthritis become restricted to common clonotypes during disease progression. Int Immunol 2004;16:131-8.
35. Butler DM, Malfait AM, Mason LJ et al. DBA/1 mice expressing the human TNF-α transgene develop a severe, erosive arthritis. J Immunol 1997;159:2867-76.
36. Hill JA, Southwood S, Sette A et al. The conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule. J Immunol 2003;171:538-41.
37. + T-cell immune response. Immunol Rev 1999;172:335-43.
38. Ito K, Hong-Jin B, Molina M et al. HLA-DR4-IE chimeric class II transgenic, murine class II deficient mice are susceptible to experimental allergic encephalomyelitis. J Exp Med 1996;183:2635-44.
39. Taneja V, David CS. HLA class II transgenic mice as models of human diseases. Immunol Rev 1999;169:67-79.
40. Girbal-Neuheuser E, Durieux JJ, Arnaud M et al. The epitopes targeted by the rheumatoid arthritis-associated anti-filaggrin autoantibodies are posttranslationally generated on various sites of (pro)-filaggrin by deimination of arginine residues. J Immunol 1999;162:585-94.
41. Suzuki A, Yamada R, Chang X et al. Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis. Nat Genet 2003;34:395-402.
42. Schellekens GA, de Jong BAW, van den Hoogen FHJ, van den Putte LBA, van Venrooij WJ. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest 1998;101:273-81.
43. Vossenar ER, Nijenhuis S, Helsen MMA et al. Citrullination of synovial proteins in murine models of rheumatoid arthritis. Arthritis Rheum 2003;48:2489-500.
44. Ji H, Gauguier D, Ohmura K et al. Genetic influences on the end-stage effector phase of arthritis. J Exp Med 2001;194:321-30.
45. Brand DD, Marion TN, Myers LK et al. Auto-antibodies to murine type II collagen in collagen-induced arthritis. A comparison of susceptible and non-susceptible strains. J Immunol 1996;157:5178-84.
46. Verheijden GFM, Rijnders AWN, Bos E et al. Human cartilage glycoprotein-39 as a candidate auto-antigen in rheumatoid arthritis. Arthritis Rheum 1997;40:1115-25.
47. Hollo K, Giant TT, Garzo M et al. Complex pattern of Th1 and Th2 activation with a preferential increase of auto-reactive Th1 cells in BALB/c mice with proteoglycan (aggrecan)-induced arthritis. Clin Exp Immunol 2000;120:167-73.
48. Suzan M, Boned A, Lieberkind J, Valsted F, Rubin B. The 5936 Ig-idiotype(s): genetic linkage to Ig-Ch loci, T-cell dependence of synthesis and possible specificities. Scand J Immunol 1981;14:673-85.
49. Rubin B, Wigzell H. The immune response to hapten-autologous protein conjugates in the mouse. III. Specificity of non-thymus processed (B) and thymus-processed (T) lymphocytes. J Exp Med 1973;137:911-31.
50. Fugger LP, Michie SA, Rulifson I et al. Expression of HLA-DR4 and human CD4 transgenes in mice determines the variable region beta-chain T-cell receptor repertoire and mediates an HLA-DR-restricted immune response. Proc Natl Acad Sci USA 1994;91:6151-6.
51. Hill J, Cairns E, Bell D. Citrullinated fibrinogen induces arthritis in DR4-transgenic mice. Ontario: University of London, 2003. [abstract].
52. Andersson EC, Hansen BE, Jacobsen H et al. Definition of MHC and T cell receptor contacts in the HLA-DR4 restricted immunodominant epitope in type II collagen and characterization of collagen-induced arthritis in HLA-DR4 and human CD4 transgenic mice. Proc Natl Acad Sci USA 1998;95:7574-8.
53. Cohen IR, Ben-Nun A, Holoshitz J, Maron R, Zerubavel R. Vaccination against autoimmune disease with lines of autoimmune T lymphocytes. Immunol Today 1983;4:227-30.
54. Morgan ME, Sutmuller RPM, Witteveen HJ et al. CD25+ cell depletion hastens the onset of severe disease in collagen-induced arthritis. Arhtritis Rheum 2003;48:1452-60.
55. Malmström V, Bäcklund J, Jansson L, Kihlberg J, Holmdahl R. T cells that are naturally tolerant to cartilage-derived type II collagen are involved in the development of collagen-induced arthritis. Arthritis Res 2000;2:315-26.
56. Rubin B. Regulation of helper cell activity by specifically adsorbable T lymphocytes. J Immunol 1976;116:80-5.
57. Schirrmacher V, Wigzell H. Immune responses against native and chemically modified albumins in mice. I. Analysis of B and T cell responses against methylated bovine serum albumin. J Exp Med 1974;136:1616-31.
58. Bäcklund J, Carlsen S, Höger T et al. Predominant selection of T cells specific for the glycosylated collagen type II epitope (263-270) in humanized transgenic mice and in rheumatoid arthritis. Proc Natl Acad Sci USA 2002;99:9960-5.
59. Lopez-Hoyos M, Marquina R, Tamayo E et al. Defects in the regulation of B cell apoptosis are required for the production of citrullinated peptide autoantibodies in mice. Arthritis Rheum 2003;48:2353-61.
60. Terato K, Hasty KA, Reife RA et al. Induction of arthritis with monoclonal antibodies to collagen. J Immunol 1992;148:2103-8.
61. Hebeis BJ, Klenovsek K, Rohwer P et al. Activation of virus-specific memory B cells in the absence of T cell help. J Exp Med 2004;199:593-602.
62. Kyburz D, Corr M, Brinson DC et al. Human rheumatoid factor production is dependent on CD40 signaling and autoantigen. J Immunol 1999;163:3116-22.
63. Malmström V, Michaëlsson E, Burkhardt H et al. Systemic versus cartilage-specific expression of a type II collagen-specific T-cell epitope determines the level of tolerance and susceptibility to arthritis. Proc Natl Acad Sci USA 1996;93:4480-5.
64. Malmström V, Ho KKY, Lun J et al. Arthritis susceptibility in mice expressing human type II collagen in cartilage. Scand J Immunol 1997;45:670-7.
65. Sercarz EE, Maverakis E. MHC-guided processing: binding of large antigen fragments. Nat Rev Immunol 2003;3:621-9.
66. Lee P, Matsueda GR, Allen PM. T cell recognition of fibrinogen. A determinant on the Aα-chain does not require processing. J Immunol 1998;140:1063-8.